Optimi Competitors

Founded in 1986, the Multidisciplinary Association for Psychedelic Studies (MAPS) is a 501(c)(3) non-profit research and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana. We further our mission by: ● Developing psychedelics and marijuana into prescription medicines ● Training therapists and working to establish a network of treatment centers ● Supporting scientific research into spirituality, creativity, and neuroscience ● Educating the public honestly about the risks and benefits of psychedelics and marijuana

MycoMedica Life Sciences is a pioneering biopharmaceutical company whose mission is to revolutionize the development of a new class of safe and efficacious psychedelic medications for mental health and neurodegenerative disorders. We believe that every individual deserves access to quality healthcare and are committed to ensuring that no one is left behind in their pursuit of whole human health.

Collective Evolution explores news, ideas and breakthroughs in human consciousness that are a core part of what is evolving humanity’s consciousness in each moment. We’re on a mission to foster a shift in the way we see ourselves, each other and the world. Effectively inspiring readers to realize that change starts within. This shift will lead to a world where humanity can thrive.